» Authors » Dingyao Zhang

Dingyao Zhang

Explore the profile of Dingyao Zhang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 191
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Tian J, Kang S, Zhang D, Huang Y, Zhao M, Gui X, et al.
Clin Immunol . 2023 Feb; 248:109267. PMID: 36804224
Objectives: To estimate the global and country-specific unbiased epidemiological data of SSc. Methods: Epidemiological studies were systematically searched in four databases. A Bayesian hierarchical linear mixed model was constructed to...
12.
Tian J, Zhang D, Yao X, Huang Y, Lu Q
Ann Rheum Dis . 2022 Oct; 82(3):351-356. PMID: 36241363
Objectives: To quantify global, regional and country-specific estimates of epidemiology of systemic lupus erythematosus (SLE). Methods: Four databases were systematically searched, and a Bayesian hierarchical linear mixed model was constructed...
13.
Liu J, Zhang D, Brahmandam A, Matsubara Y, Gao M, Tian J, et al.
J Vasc Access . 2022 Jun; 25(1):172-186. PMID: 35686495
Background: Arteriovenous fistulae (AVF) are the preferred access for hemodialysis but still have poor rates of maturation and patency limiting their clinical use. The underlying mechanisms of venous remodeling remain...
14.
Zhang D, Tian J, Wang Y, Lu J
Bioinformatics . 2022 Mar; 38(9):2437-2443. PMID: 35294970
Motivation: The coronavirus disease 2019 (COVID-19) pandemic has highlighted the threat of emerging respiratory viruses and has exposed the lack of availability of off-the-shelf therapeutics against new RNA viruses. Previous...
15.
Tian J, Zhang D, Kurbatov V, Wang Q, Wang Y, Fang D, et al.
EMBO J . 2021 Feb; 40(7):e106065. PMID: 33615517
5-Fluorouracil (5-FU) is a widely used chemotherapeutic drug, but the mechanisms underlying 5-FU efficacy in immunocompetent hosts in vivo remain largely elusive. Through modeling 5-FU response of murine colon and...
16.
Zhang D, Lu J
bioRxiv . 2020 Aug; PMID: 32817944
The COVID-19 pandemic has exposed global inadequacies in therapeutic options against both the COVID-19-causing SARS-CoV-2 virus and other newly emerged respiratory viruses. In this study, we present the VirusSi computational...